Clinical trial

Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure

NCT01936129

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-09-01

PhasePHASE3

Study timeline

Study start (unknown)2010-09-01Date precision: month

Registry last updated2013-09-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Angle-closure, Primary, Acuteunresolved

Interventions

CopaxoneDRUG · verified · RxNorm: Copaxone

Placebo (buffered normal saline w/v)DRUG

Sponsors & collaborators

Singapore Eye Research Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01936129 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.